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Abstract
The Tax1 oncoprotein encoded by Human T-lymphotropic virus type I is a major determinant of
viral persistence and pathogenesis. Tax1 affects a wide variety of cellular signalling pathways leading
to transcriptional activation, proliferation and ultimately transformation. To carry out these
functions, Tax1 interacts with and modulates activity of a number of cellular proteins. In this review,
we summarize the present knowledge of the Tax1 interactome and propose a rationale for the
broad range of cellular proteins identified so far.
1 Introduction
Human T-lymphotropic viruses (HTLV-1 to -4) belong to
the Deltaretrovirus  genera of the Orthoretrovirinae sub-
family. HTLV-1 was the first discovered human retrovirus
in the early eighties [1]. HTLV-2 was described two years
later [2] whereas HTLV-3 and -4 subtypes were isolated
only recently [3,4]. HTLV-1 is the etiological agent of an
aggressive leukemia called adult T-cell leukemia/lym-
phoma (ATL) and a neurodegenerative disease, tropical
spastic paraparesis/HTLV associated myelopathy (TSP/
HAM). Isolated from a case of hairy-cell leukemia, HTLV-
2 is by far less pathogenic although its involvement in the
development of TSP has been reported [5,6]. HTLV-3 and
-4 have not yet been associated to any pathology, likely
due to their recent identification and to the low number
of isolates. Three HTLV subtypes have closely related sim-
ian viruses (named STLV-1, -2 and -3) while a STLV-5
strain is presently still devoid of a human counterpart [7].
Another related deltaretrovirus, bovine leukemia virus
(BLV) is the etiological agent of enzootic bovine leuke-
mia. BLV infection of sheep has been used as an animal
model for HTLV [8].
The genome of the HTLV viruses contain typical structural
and enzymatic genes (gag, prt, pol and env) flanked by two
long terminal repeats (LTRs) but also harbors an addi-
tional region called pX located between the env gene and
the 3'-LTR. This region contains at least four partially over-
lapping reading frames (ORFs) encoding accessory pro-
teins (p12I, p13/p30II), the Rex post-transcriptional
regulator (ORF III) and the Tax protein (ORF IV). The
complementary strand of the HTLV-1 proviral genome is
also transcribed, yielding spliced isoforms of the Hbz fac-
tor [9-11]. Hbz interacts with factors JunB, JunD, CREB
and CBP/p300 to modulate gene transcription [12-14].
There is an inverse relantionship between high Hbz and
low Tax expresssion in primary ATL [15].
Among proteins encoded by HTLV-1, Tax1 exerts an
essential role in viral transcription as well as in cell trans-
formation [11,16-18]. These pleiotropic functions are
directed by a very wide spectrum of interactions with cel-
lular proteins. In this review, we summarize the current
knowledge pertaining to the Tax1 interactome and focus
Published: 14 August 2008
Retrovirology 2008, 5:76 doi:10.1186/1742-4690-5-76
Received: 19 June 2008
Accepted: 14 August 2008
This article is available from: http://www.retrovirology.com/content/5/1/76
© 2008 Boxus et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Retrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
Page 2 of 24
(page number not for citation purposes)
more particularly on its impact on transcription, viral per-
sistence and transformation.
2 Interaction of Tax1 with transcription factors 
and post-transcriptional regulators
In eukaryotes, initiation and elongation of gene transcrip-
tion requires decondensation of the locus, nucleosome
remodeling, histone modifications, binding of transcrip-
tional activators and coactivators to enhancers and pro-
moters and recruitment of the basal transcription
machinery to the core promoter [19,20]. Tax1 is a pleio-
tropic transcription factor that interferes with several of
these mechanisms and modulates transcription of a wide
range of cellular genes. In fact, Tax1 deregulates expres-
sion of more than one hundred genes [21] through inter-
actions with transcriptional activators, basal transcription
factors and proteins involved in chromatin remodeling.
Moreover, Tax1 associates with proteins involved post-
transcriptionnal control of mRNAs and further modulates
gene expression.
2.1 Transcriptional activators and repressors
2.1.1 CREB/ATF factors
Tax1 was initially described as an activator of LTR-directed
transcription [22]. Three imperfectly conserved 21-base-
pair (bp) repeat sequences called (TxRE) located in the U3
region of the LTR are required and sufficient to confer
Tax1 responsiveness [23]. The TxRE element contains an
octamer motif TGACG(T/A)(C/G)(T/A) that is flanked by
a G stretch and a C stretch at the 5' and 3' sides, respec-
tively [24]. Interestingly this octamer shares homology
with the consensus cAMP-responsive element (CRE) 5'-
TGACGTCA-3' [24]. Nevertheless, Tax1 exhibits poor
affinity for DNA and does not bind directly to the TxRE
element [25] but interacts with CRE-binding/activating
transcription factors (CREB/ATF). In fact, Tax1 interacts in
vitro with a number of proteins of the CREB/ATF family of
transcription factors: CREB, CREM, ATF1, ATF2, ATF3,
ATF4 (CREB2) and XBP1 (X-box-binding protein 1) [26-
31]. These proteins share a common cluster of basic resi-
dues allowing DNA binding and a leucine zipper (b-Zip)
domain involved in homo- and heterodimerization.
Dimer formation modulates their DNA binding specifi-
city and transcriptional activity [32]. Biochemical studies
revealed that Tax1 promotes formation of a Tax1-CREB/
ATF-TxRE ternary complex in vitro by interacting with the
b-Zip domain of CREB/ATF factors. Mechanistically, Tax1
enhances the dimerization of CREB/ATF factors, increases
their affinity for the viral CRE [33-36] and further stabi-
lizes the ternary complex through direct contact of the
GC-rich flanking sequences [37,38]. Tax1 then recruits co-
activators (CBP/p300 and P/CAF) to facilitate transcrip-
tional initiation (see 2.3.1). The ability of Tax1 to dimer-
ize is required for efficient ternary complex formation and
for optimal transactivation [39,40]. Interaction of Tax1-
CREB/ATF with the LTR promoter DNA was further
explored by chromatin immunoprecipitation (ChIP) [41].
In HTLV-1 infected human T-cells (SLB-1), Tax1 and a
plethora of CREB/ATF factors as well as other b-Zip pro-
teins bind to the LTR promoter, further confirming inter-
action in vivo. The fact that Tax1 interacts with ATFx adds
another level of complexity since this factor represses
Tax1-mediated LTR activation [42]. Tax1 is thus able to
interact with positive as well as with negative CREB/ATF
factors to modulate LTR promoter-directed activity.
Tax1 also binds to CREB co-activator proteins called trans-
ducers of regulated CREB activity (TORCs). In fact, Tax1
interacts with the three members of this family (TORC1,
TORC2 and TORC3) [43,44] and TORCs cooperate with
Tax1 to activate the LTR in a CREB and p300-dependent
manner. Thus, TORCs are thought to associate with the
Tax1 ternary complex and participate to transcriptional
activation.
CREB/ATF members play a role in cell growth, survival
and apoptosis by regulating CRE-directed gene transcrip-
tion in response to environmental signals such as growth
factors or stress [32,45]. Furthermore, CREB/ATF proteins
also have significant impact on cancer development [45].
Depending on the cell type, Tax1 mutants deficient for
CREB activation are incompetent for transformation or
induction of aneuploidy [46-50]. Tax1 activates a variety
of cellular genes through its interactions with CREB/ATF
proteins, for example those encoding interleukin 17 or c-
fos [51,52]. Conversely, Tax1 also represses expression of
genes like cyclin A, p53 and c-myb by targeting CREB/ATF
factors [53-55]. Transcriptomic profiling of cells express-
ing either a wild-type or a CREB-deficient Tax1 protein
revealed several cellular genes controlled by CRE elements
activated by Tax1 [50]. Among these, Sgt1 (suppressor of
G2 allele of SKP1) and p97(Vcp) (valosin containing pro-
tein) have functions in spindle formation and disassem-
bly, respectively.
Together, these reports thus demonstrate that Tax1 inter-
acts with a series of CREB/ATF factors and modulates
expression of viral and cellular genes through CRE ele-
ments. The specific contribution of each CREB/ATF mem-
ber in Tax1-mediated gene transcription remains unclear.
2.1.2 Serum responsive factor and members of the ternary complex 
factor
HTLV-1 infected T-cell lines expressing Tax1 display
increased expression of AP1 (activator protein 1), a homo-
or heterodimeric complex of Fos (c-Fos, FosB, Fra1 and
Fra2) and Jun (c-Jun, JunB and JunD) [56,57]. Fos and Jun
are under the transcriptional control of the serum respon-
sive factor (SRF) in response to various stimuli such as
cytokines, growth factors, stress signals and oncogenes.Retrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
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SRF binds to the SRF responsive element (SRE) located in
the Fos/Jun promoters which contains two binding sites:
a CarG box (CC(A/T)6GG) and an upstream Ets box
(GGA(A/T)). Once SRF occupies the CArG box, the ter-
nary complex factor (TCF) establishes protein interaction
with SRF and subsequently binds the upstream Ets site.
This complex then recruits the co-activators P/CAF and
CBP/p300 to activate transcription.
In reporter assays, Tax1 activates transcription of promot-
ers under the control of SRE motifs [52,56,58] without
direct binding to the DNA but through interactions with
transcription factors associated with the SRF pathway.
Tax1 has been shown to bind directly to SRF [59-61] and
to various members of the TCF complex such as Sap1 (SRF
accessory protein 1), Elk1, Spi1 (spleen focus forming
virus (SFFV) proviral integration oncogene 1) and Ets1
[49,62,63]. Tax1 interaction with SRF results in increased
binding of SRF to the SRE and altered site selection [64].
Once the complexes are stabilized, Tax1 recruits the co-
activators CBP/p300 and P/CAF (see 2.3.1) and mediates
transactivation [63].
It thus appears that Tax1 activates transcription from
CREB- and SRF-responsive sites through a similar mecha-
nism which involves its interaction with transcription fac-
tors resulting in enhanced DNA binding, altered site
selection and coactivator recruitment [16].
2.1.3 Nuclear factors κB (NF-κB)
HTLV-1 infected cells display increased expression of var-
ious cytokines and cytokine receptors such as interleukin
2 (IL2) and the α-subunit of its high-affinity receptor
complex (IL2Rα) [65-68]. Induction of IL2 and IL2Rα
expression is mediated by Tax1 activation of the NF-κB/
Rel family of transcription factors [69,70]. By modulating
expression of a wide range of genes involved in apoptosis,
proliferation, immune response and inflammation, NF-
κB is thought playing a central role in Tax1-mediated cell
transformation [16].
In mammals, the NF-κB family of transcription factors is
composed of five structurally related members, RelA, RelB
(p65), c-Rel, NF-κB1 (p50/p105) and NF-κB2 (p52/p100)
which form various dimeric complexes that transactivate
or repress target genes bearing a κB enhancer [71,72].
p105 and p100 are precursor proteins that are processed
proteolytically to the mature p50 and p52 forms, respec-
tively. These factors share a common Rel-homology
domain (RHD) mediating their dimerization, DNA bind-
ing and nuclear localization. In non-activated cells, NF-κB
dimers are trapped in the cytoplasm by inhibitory pro-
teins called IκBs such as p105, p100, IκBα, IκBβ and IκBγ
(C-terminal region of p105), that mask the nuclear local-
ization signal of NF-κB factors through physical interac-
tion [71,72]. NF-κB activation involves phosphorylation
of IκB inhibitors by the IκB kinase (IKK), which triggers
their ubiquitination and subsequent proteasomal degra-
dation, resulting in nuclear translocation of NF-κB dimers
[72,73].
Tax1 associates with RelA, c-Rel, p50 and p52 after their
translocation in the nucleus [61,74,75] but also directly
recruits RelA from the cytoplasm [76,77]. After interaction
with these NF-κB factors, Tax1 increases their dimeriza-
tion which is essential for binding to target promoters
[61,75,78]. When the complex is bound to the promoter,
Tax1 recruits the CBP/p300 and PCAF co-activators
[79,80], leading to transcriptional activation
2.1.4 Other transcription factors
Tax1 has been shown to associate with CCAAT binding
proteins such as NF-YB (nuclear factor YB subunit) and C/
EBPβ (CCAAT/enhancer-binding protein β) [81-83].
Through its binding to NF-YB, Tax1 activates the major
histocompatibility complex class II promoter [82].
Besides, C/EBPβ acts as a transcriptional repressor by pre-
venting Tax1 binding to the LTR [83]. On the other hand,
Tax1 increases binding of C/EBPβ to and activates the IL-
1β promoter [81]. It is noteworthy that C/EBP factors have
been implicated in regulation of cellular proliferation and
differentiation but also in tumor formation and leukemia
development [84].
Tax1 forms ternary complexes in vitro with Sp1 (specificity
protein 1)/Egr1 (early growth response 1) [85] and Sp1/
Ets1 [62], thereby participating directly in transcriptional
activation of the c-sis/PDGF-B (platelet-derived growth
factor B) proto-oncogene and PTHrP (parathyroid hor-
mone-related protein) P2 promoters, respectively. Of
note, PTHrP is up-regulated during immortalization of T-
lymphocytes by HTLV-1 and plays a primary role in the
development of humoral hypercalcemia of malignancy
that occurs in the majority of patients with ATL [86,87].
Tax1 further associates with nuclear respiratory factor 1
(NRF1) and activates the CXCR4 chemokine receptor pro-
moter [88].
Finally, the transcriptional repressor MSX2 (msh home-
obox homolog 2) impairs Tax1 mediated transactivation
through direct binding [89].
2.2 Basal transcription factors
Tax1 interacts with TFIIA (transcription factor II A) and
with two subunits of TFIID: TBP (TATAA-binding protein)
and TAFII28 (TBP-associated factor II 28) [90-92]. These
basal transcription factors compose the preinitiation tran-
scription complex responsible for the recruitment of RNA
polymerase II. Owing to this interaction, Tax1 increasesRetrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
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the binding of TBP to the TATAA site and further stimu-
lates transcription initiation from the LTR [93].
2.3 Chromatin modifying enzymes
Structural variations of chromatin range from condensed
heterochromatin to more open euchromatin, a process
that depends on antagonistic effects between multiple
protein complexes. Among the complexes affecting chro-
matin structure, there are those who are capable of alter-
ing the histones themselves, the histone deacetylases
(HDAC), acetyltransferases (HAT), demethylases (HDM)
and methyltransferases (HMT), and those that use the
energy of ATP to change the structure of the nucleosome
as the SWI/SNF complex [94-96]. Tax1 expression and
HTLV-1 infection both reduce histone levels in T cells
[97]. Moreover, Tax1 interacts directly and recruits several
proteins involved in chromatin remodeling to modulate
gene transcription. The involvement of Tax1-binding pro-
teins in transcriptional activation has been primarily
described in the context of the viral LTR. Nevertheless,
similar mechanisms are also likely to participate in the
activation of cellular promoters.
2.3.1 HATs
Acetylation of lysine residues located in the N-terminal
tails of histone proteins by HATs is a crucial step for acti-
vation of gene transcription. Tax1 interacts with several
HATs: p300, its homologous CREB binding protein (CBP)
and p300/CBP associated factor (P/CAF) [98-102]. Tax1
recruits the CBP/p300 and P/CAF once the Tax1-CREB-
TxRE complex is stabilized (see 2.1.1), each of which
being able to enhance Tax1-mediated transactivation of a
transiently transfected LTR reporter. CBP/p300 and P/CAF
bind independently on different regions of Tax1 and
interaction of Tax1 with these two cofactors is required for
optimal transcriptional activity from transiently trans-
fected but also stably integrated LTR reporters [101-103].
Surprisingly, P/CAF but not CBP/p300 is able to enhance
transcription from the LTR independently of its HAT activ-
ity [101,103]. Tax1 mediates recruitment of CBP/p300 on
reconstituted chromatin templates and facilitates transac-
tivation in a HAT-activity dependent manner [104,105].
CBP/p300 presence at the LTR template correlates with
histone H3 and H4 acetylation as well as increased bind-
ing of basal transcription factors and RNA polymerase II.
ChIP analyses with HTLV-1 infected T cell lines indicate
that Tax1, CBP/p300 and acetylated histone H3 and H4
are indeed associated with the LTR promoter [41,105].
There is a long lasting debate about how Tax1 recruits
CBP/p300 at the Tax1-CREB/ATF-TxRE complex. Phos-
phorylation of CREB at serine 133 by protein kinases A or
C is required for CBP/p300 recruitment via physical inter-
action with the KIX domain [106-108]. It has long been
suggested that Tax1 bypasses the requirement for CREB
phosphorylation to recruit coactivators [98,100]. Never-
theless, recent reports indicate that Tax1 rather cooperates
with phosphorylated CREB (pCREB) to induce transacti-
vation [109,110]. High levels of pCREB are detected in
Tax1 expressing cells and in HTLV-1-infected human T-
lymphocytes [110]. Tax1 and pCREB interact simultane-
ously at two distinct binding sites on the KIX domain
forming a very stable complex with the viral CRE
[110,111]. Both CREB phosphorylation and Tax1 binding
are needed for efficient interaction of full-length CBP to
pCREB and subsequent transcriptional activation [112].
Finally, Tax1 is able to repress the activity of some tran-
scription factors by competitive usage of CBP, p300 and
P/CAF. As mentionned above, stable complex formation
between Tax1, a transcription factor (e.g. CREB or SRF)
and CBP/p300 contributes to transcriptional activation.
On the contrary, when Tax1 has poor affinity for a tran-
scription factor (e.g. p53, MyoD or STAT2), it interferes
with co-activator recruitment and prevents their activition
[113-116]. Although controversial, this mechanism
termed trans-repression could partipate to p53 inactiva-
tion in Tax1 expressing cells and HTLV-1 infected lym-
phocytes (for a review see [117]).
2.3.2 HDACs
Among three HDACs (-1, -2 and -3) interacting with the
viral LTR in HTLV infected cell lines [118], Tax1 binds
directly to HDAC1. HDAC1 overexpression represses
Tax1-mediated transactivation owing to its HDAC activity
[119]. Nevertheless, the presence of Tax1 and HDAC1 on
the viral promoter is mutually exclusive [118,120].
HDAC1 binds to the non-activated LTR and is released
from the promoter through physical interaction with Tax1
allowing recruitment of co-activators and transcription
initiation. Tax1 is also able to tether HDAC1 to the tyro-
sine phosphatase SHP1 promoter and selectively down-
regulate gene expression [121].
HDACs form multiprotein complexes together with DNA-
histone binding proteins such as SMRT (silencing media-
tor for retinoid and thyroid receptor) and MBD2 (methyl-
CpG-binding domain 2) that both interact with Tax1 and
are involved in Tax1 transcriptional activities [122,123]. It
thus seems that Tax1, through direct association with
HDACs and HDAC-containing complexes is able to selec-
tively activate or repress viral and cellular genes expres-
sion.
2.3.3 HMTs and HDMs
Mono-, di- and tri-methylation of histone H3 at lysine 9
(H3K9) play a crucial role in structural modification of
chromatin. Tax1 associates with two enzymes involved in
regulation of H3K9 methylation: SUV39H1 (suppressor
of variegation 3–9 homologue 1), a HMT and JMJD2ARetrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
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(Jumonji containing domain 2A), a HDM [124,125].
Methylated H3K9 is a hallmark of transcriptionally inac-
tive chromatin whereas demethylation rather promotes
transcriptional activation [126]. SUV39H1 interacts with
Tax1 and represses Tax1-mediated transactivation of the
LTR [124]. JMJD2A is highly expressed in HTLV-1 infected
cell lines but its role on Tax1-mediated transcription is
currently unknown [125].
Methylation of histone H3 at arginine residues is another
important regulatory mechanism of transcriptionnal reg-
ulation. Tax1 associates with coactivator-associated
arginine methyltransferase (CARM1), which preferen-
tially induces methylation at residues R2, R17 and R26 of
histone H3 [127]. CARM1 is recruited by Tax1 to the LTR
and increases Tax1-mediated transactivation of the LTR.
Consistently, silencing of CARM1 impairs Tax1 transcrip-
tional activation, R2-, R17- and R26-methylated histone
H3 proteins being present on the LTR promoter in HTLV-
1 infected cells.
Tax1 thus interacts with different histone methyltran-
ferases and demethylases to modulate histone methyla-
tion and regulate gene expression.
2.3.4 The SWI/SNF complex
The SWI/SNF (Switch/Sucrose Non Fermentable) com-
plex utilizes the energy of ATP hydrolysis to remodel chro-
matin structures, thereby allowing transcription factors to
gain access to DNA during initiation and elongation steps
of transcription [128,129]. Tax1 interacts with different
components of SWI/SNF: BRG1, BAFs 53, 57 and 155
[130]. Overexpression and silencing of BRG1 increments
and impedes Tax1 transactivation of the LTR, respectively
[130]. It was first suggested that Tax1 targets BRG1/BRM
downstream of RNA polymerase II in order to prevent
stalling of transcription. This model was apparently con-
tradicted by the capacity of Tax1 to efficiently activate
transcription from chromosomally integrated LTR and
NF-κB promoter in a BRG1/BRM deficient cell line [131].
Nevertheless, this observation does not exclude that fac-
tors of the SWI/SNF complex cooperate with Tax1 to pro-
mote gene transcription. Consistent with this idea, Tax1
cooperates with SWI/SNF complex and RNA polymerase
II to promote nucleosome eviction during transactivation
[132]. Histone eviction increases accessibility of DNA to
transcription factors and requires activity of SWI/SNF and
RNA polymerase II [128,133]. Of note, Tax1 may also
impact indirectly on SWI/SNF function [134] by interac-
tion with DNA topoisomerase I [135].
Tax1 is thus able to target SWI/SNF complex components
to promote nucleosome displacement and participate to
transcriptional activation.
2.4 Positive transcription elongation factor b (P-TEFb) and 
sc35
The switch from initiation of transcription to elongation
requires promoter clearance and phosphorylation of the
RNA polymerase II carboxyl-terminal domain (CTD)
[19]. Phosphorylaton of CTD on serine 5 (S5) and 2 (S2)
requires the kinase activities of the basal transcription fac-
tor TFIIH and CDK9, respectively. In the cell, CDK9
together with regulatory subunits cyclin T1, -T2, or -K
compose the positive transcription elongation factor b (P-
TEFb) that ensures the elongation phase of transcription
by RNA polymerase II [136,137]. Tax1 recruits P-TEFb to
the viral promoter by interacting with cyclin T1 and CDK9
silencing or depletion inhibits Tax1-mediated transactiva-
tion [138,139]. In fact, recruitment of P-TEFb activity to
the LTR promoter increases CTD phosphorylation at ser-
ine S2 (but not S5) and allows transcriptional activation
[138].
Recent data suggest that the splicing factor sc35 has a crit-
ical role in P-TEFb recruitment and positively impacts on
transcription [140]. Tax1 binds and colocalizes with sc35
and P-TEFb in nuclear transcriptional hot spots termed
speckled structures [141].
2.5 Nuclear receptors
Nuclear receptors (NR) belong to a large family of ligand-
activated transcription factors that regulate gene expres-
sion in response to steroids, retinoids, and other signaling
molecules [142]. Tax1 functions as a general transcrip-
tional repressor of nuclear receptors such as glucocorti-
coid receptors (GR) [143]. A Tax1-binding protein
referred to as Tax1BP1 and identified in a yeast two hybrid
screen acts as a transcriptional co-activator for NR. Tax1
represses GR signaling by dissociating Tax1BP1 from the
receptor-protein containing complex. Consistently,
Tax1BP1 overexpression restores GR signaling in Tax1-
expressing cells [144].
2.6 Post-transcriptional and translational regulators
Tax1-directed gene expression is further regulated at the
post-transcriptional and translational levels through pro-
tein-protein interactions. Among these, Tax1 associates
with TTP, Int6 and TRBP.
2.6.1 Tristetraprolin (TTP)
TTP belongs to a family of adenine/uridine-rich element
(ARE)-binding proteins that contain tandem CCCH zinc
finger RNA-binding domains [145]. TTP is therefore an
important player in posttranscriptional regulation of
mRNA containing ARE elements. Indeed, TTP delivers
ARE-containing mRNAs in discrete cytoplasmic regions,
called RNA granules, involved in regulation of translation
or decay of these transcripts [146]. The repertoire of ARE-
containing genes includes Tumor Necrosis Factor αRetrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
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(TNFα) and Granulocyte Macrophage-Colony-Stimulat-
ing Factor (GM-CSF) [145] involved in cell signaling,
metabolism, cell proliferation, immune response, death,
differentiation and morphogenesis [147].
Tax1 interacts with TTP and redirects TTP from the cyto-
plasm to the nuclear compartment as well as in a region
surrounding the nucleus [148]. Through its interactions
with TTP, Tax1 stabilizes TNFα mRNA and indirectly
increases TNFα protein expression. This observation is of
importance for the cell transformation process induced by
HTLV-1, because TNFα overexpression plays a central role
in pathogenesis.
2.6.2 Int6 and TRBP
Tax also binds Int6 (Integration site 6) and TRBP (TAR
binding protein) that regulate translation and RNA inter-
ference, respectively. In fact, Int6 is a subunit of transla-
tion initiation factor eIF3, which regulates mRNA binding
to the ribosome [149] while TRBP (TAR binding protein)
is a componant of RISC (RNA-induced silencing complex)
that mediates RNA interference [150]. Currently, the role
of these interactions remains unclear.
2.7 A global model of Tax1 transactivation
Most of the data summarized in the former paragraphs
relate to transcriptional activation of the LTR by Tax1
although it is likely that similar mechanisms also pertain
to cellular promoters. Figure 1 recapitulates the mecha-
nisms of transactivation: Tax1 relieves transcriptional
repression through direct interaction with HDAC (i.e.
HDAC1) and/or HMT (panel A). Tax1 interacts with
CREB/ATF factors (CA) and enhances their binding to the
LTR (panel B). When complexes are stabilized on the pro-
moter, Tax1 recruits histone modifying enzymes and
chromatin remodelers. This step affects chromatin struc-
ture and allows binding of basal transcription factors on
the TATA box that is further stabilized by Tax1 interaction
with TFIIA, TFIID and TBP (panel C). Once the initiation
complex is formed, Tax1 recruits the P-TEFb factor, lead-
ing to CTD phosphorylation and processive elongation
(panel D). Finally, interaction of Tax1 with SWI/SNF pre-
vents stalling of transcription elongation.
3 Tax1 interaction with proteins involved in cell 
signaling
3.1 NF-κB signaling
NF-κB can be activated by a series of stimuli such as anti-
gens or cytokines that trigger two alternative pathways
(so-called canonical and non-canonical). The canonical
pathway is engaged in response to inflammatory stimuli
(such as TNF-α and interleukin 1 IL-1), T-cell receptor
activation or exposure to lipopolysaccharide (LPS). This
pathway begins with the phosphorylation of IκB inhibi-
tors by the IκB kinase (IKK), a complex of IKKα, IKKβ and
IKKγ/NEMO (NF-κB Essential Modulator). IKK is acti-
vated by a mitogen-activated protein kinase kinase kinase
(MAP3K) that phosphorylates the IKKα and IKKβ subu-
nits. Phosphorylation of IκB inhibitors triggers their ubiq-
uitination and subsequent degradation by the 26S
proteasome, resulting in nuclear translocation of NF-κB
dimers (e.g. p50/relA) [72,73]. The non-canonical path-
way, which can be induced by stimuli such as CD40 lig-
and, involves IKKα activation upon phosphorylation by
NF-κB inducing kinase (NIK). IKKα then phosphorylates
the C-terminal region of p100 leading to subsequent
processing of the p100/RelB complex into p52/RelB and
its translocation into the nucleus [151]. Interestingly,
p52/RelB and p50/RelA dimers target distinct κβ enhanc-
ers thereby activating different gene subsets.
Tax1 stimulates both canonical and non-canonical path-
ways and constitutively activates NF-κB in HTLV-1
infected cells [152-154]. The above mentionned interac-
tions of Tax1 with NF-κB transcription factors (see 2.1.3)
only explains part of Tax1-mediated NF-κB activation
since this completion of this process also requires cyto-
plamic events. In the canonical pathway, Tax1 associates
with the IKKγ/NEMO subunit [155,156] as well as with
activating upstream kinases such as MAPK/ERK kinase
kinase 1 (MEKK1) and TGF-β activating kinase 1 (TAK1)
[157,158] (see 3.2). Tax1 thus connects activated kinases
to the IKK complex and forces the phosphorylation of
IKKα and IKKβ leading to degradation of IκBα and IκBβ
[155,156]. In addition, Tax1 binds directly to the IKKα
and IKKβ subunits and activates their kinase activity inde-
pendently of the upstream kinases [159]. Consistently,
silencing of MEKK1 and TAK1 does not impair Tax1-
induced NF-κB activation [160]. A third level of Tax1
interference with the canonical pathway is its direct bind-
ing to IκBs and their degradation independently of IKK
phosphorylation [161,162]. Tax1 further interacts two
subunits of the 20S proteasome (HsN3 and HC9), favors
anchorage of p105 and accelerates its proteolysis [163].
Tax1 thus leads to IκB degradation at multiple levels,
thereby allowing nuclear translocation of NF-κB inde-
pendently of external stimuli. Besides, activation of the
non-canonical pathway by Tax1 requires its interaction
with IKKγ and p100 [152,154]. Through these interac-
tions, Tax1 targets IKKα to p100, induces p100 processing
and nuclear translocation of the p52/RelB dimer. It thus
appears that IKKγ is an important Tax1 docking site for
activation of both pathways.
Post-translationnal modifications of IKKγ such as phos-
phorylation and K63 ubiquitination fine-tune NF-κB sig-
naling [164,165] and are modulated by Tax1 through
complex formation. In fact, PP2A activates the IKK com-
plex by promoting dephosphorylation of IKKγ serine 68
[166,167]. Tax1 complexes with PP2A and IKKγ, main-Retrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
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taining the IKK complex in an active state that is required
for activating NF-κB [168,169]. Ubiquitination is targeted
by Tax1 through interaction with Ubc13 and Tax1BP1
[170,171]. Ubc13, an E2 ubiquitin-conjugating enzyme,
is required for Tax1 interaction with IKKγ and subsequent
NF-κB activation. Tax1BP1 participates to the formation
of an ubiquitin-editing complex together with the deubiq-
uitin enzyme (DUB) A20 and plays a pivotal role in termi-
nation of NF-κB and JNK signaling by regulating the
activity of A20 [171-173]. A20 inhibits IKK activation by
cleaving K63 linked polyubiquitin chains on tumor necro-
sis factor receptor (TNFR) signaling-associated factor 6
(TRAF6), receptor interacting protein 1 (RIP1) and IKKγ
[174]. By disruption of complex A20-Tax1BP1, Tax1 inac-
tivates DUB function of A20 and prevents downregulation
of IKKγ ubiquitination. Consistent with this model, IKKγ
is ubiquitinated in Tax1-expressing cells and in a series of
HTLV-1 infected cell lines [160,171] providing a rationale
for the constitutive activation of NF-κB pathway.
3.2 Mitogen-activated kinases (MAPKs)
MAPKs are serine/threonine-specific protein kinases that
respond to external mitogen stimuli such as growth fac-
tors, cytokines or physical stress. MAPK signaling relies on
a sequential phosphorylation cascade that goes through
MAP kinase kinase kinase (MAP3K) to MAP kinase kinase
(MAP2K) and finally to MAPK. The MAPK family includes
the extracellular signal-regulated kinase protein homo-
Global model of Tax1 mediated transactivation Figure 1
Global model of Tax1 mediated transactivation. Tax1 relieves transcriptional repression of the LTR through direct 
interaction with HDAC (i.e. HDAC1) and/or HMT (panel A). Tax1 recruits CREB/ATF transcription factors (CA in panel B), 
histone modifying enzymes and chromatin remodelers (SWI/SNF, P/CAF and CBP/p300). Tax1 then allows binding of basal 
transcription factors on the TATA box (panel C). Once the initiation complex is formed, Tax1 recruits the P-TEFb factor, lead-
ing to CTD phosphorylation and processive elongation (panel D). Finally, interaction of Tax1 with SWI/SNF prevents stalling of 
transcription elongation. Adapted from [120,132,138,316].
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logues 1 and 2 (ERK1/2), ERK5, the c-Jun N-terminal
Kinase 1, 2 and 3 (JNK1/2/3) also known as stress-acti-
vated protein kinase-1 (SAPK-1), the p38 isoforms (p38α/
β/δ), ERK6, ERK3/4 and ERK7/8 [175]. Tax1 interacts with
two MAP3Ks: MEKK1 and TAK1 [157,158].
3.2.1 MEKK1
MEKK1 primarily regulates JNK and ERK1/2 but also con-
tributes to the NF-κB pathway [176,177]. Tax1 binds to
the amino terminus of MEKK1 and stimulates MEKK1
kinase activity [157]. As a result, Tax1 expression increases
IKKβ activity, leading to phosphorylation and degrada-
tion of IκBα. Dominant negative mutants of both IKKβ
and MEKK1 prevent Tax1 activation of the NFκB pathway
but, intriguingly, silencing of MEKK1 does not affect Tax1-
induced NF-κB activation [160].
3.2.2 TAK1
TAK1 is involved in JNK, TGF-β and NF-κB dependent sig-
naling pathways [178]. TAK1 acts in concert with TAK1
binding proteins (TABs) which link TAK1 to the upstream
activating TNF receptor associated factor (TRAFs) pro-
teins. TAK1 phosphorylates IKKβ and MKK6, thereby acti-
vating NF-κB and JNK [179].
TAK1 is constitutively activated in Tax1-expressing cells
and in HTLV-1 infected lymphocytes [158,160,180]. Tax1
activates TAK1 through complexation with TAK1 and
TAB2 and connects TAK1 onto the IKK complex thereby
stimulating IKK activity [180,181]. Consistently, overex-
pression of TAK1 or TAB2 increases Tax1 transactivation
of a NF-κB reporter [180,181]. However, RNA interference
of TAK1 suppresses activation of JNK and p38 but not NF-
κB. Constitutive activation of TAK1 is thus not absolutely
required for NF-κB activation [160,180]. TAK1 rather par-
ticipates to JNK signaling, which is constitutively activated
in Tax1-expressing cells, in Tax1-transformed murine
fibroblasts and in human lymphocytes transformed with
HTLV-1 [182-185].
3.3 GPS-2
By linking the nuclear co-receptor (NCoR)-HDAC3 com-
plex to intracellular JNK signaling, G protein pathway
suppressor 2 (GPS2) suppresses Ras/MAPK signaling and
JNK1 activation [183,186,187]. Indeed, the NCoR-
HDAC3 deacetylase activity represses transcription of
genes involved in JNK signaling [187]. Through interac-
tion with GPS2, Tax1 potently inhibits GPS2-mediated
inactivation of JNK signaling [183]. Tax1 thus targets mul-
tiple proteins (i.e. TAK1 and GPS2) to constitutively acti-
vate JNK signaling.
3.4 GTP-binding proteins
The guanine nucleotide-binding proteins GTPases are
molecular switches that cycle between active (GTP-
bound) and inactive (GDP-bound) states. The G protein
family includes Ras-related GTPases (or small GTPases)
and heterotrimeric G proteins (α, β and γ subunits) that
are activated by G protein-coupled receptors.
3.4.1 Rho GTPases and the cytoskeleton proteins
Tax1 complexes with several members of the small
GTPase Rho family such as RhoA, Rac, Gap1m and Cdc42
[130]. Rho GTPases are activated in response to external
stimuli (e.g. growth factor, stress, cytokines) and exert a
wide range of biochemical functions like cytoskeleton
organization, regulation of enzymatic activities as well as
gene expression [188]. Notably, Tax1 binds to proteins
involved in cytoskeleton structure and dynamics: α-
internexin, cytokeratin, actin, gelsolin, annexin and γ-
tubulin [130,189-191]. Through these interactions, Tax1
might thus connect Rho GTPases to their targets and affect
cytoskeleton organization. Consistent with this idea, Tax1
localizes around the microtubule organization center
(MTOC) and in the cell-cell contact region [192]. Thereby,
Tax1 provides an intracellular signal that synergizes with
ICAM1 engagement to cause the T-cell microtubule polar-
ization and formation of the virological synapse. Through
the formation of complexes with both Rho GTPases and
their targets, Tax1 could thus favor HTLV-1 cell-to-cell
transmission.
Since Rho GTPases modulate a wide range of signaling
networks (SRF, JNK, p38 and NF-kB) [188], complex for-
mation with Tax1 is also likely to modulate transcription.
3.4.2 Heterotrimeric Gβ subunit
Heterotrimeric G proteins are the molecular switches that
turn on intracellular signaling cascades in response to acti-
vation of G protein coupled receptor (GPCR). After bind-
ing of an agonist, the activated GPCR induces an exchange
of GDP to GTP on the Gα subunit and facilitates the dis-
sociation of GTP-bound Gβγ and Gα subunits [193].
Through its interaction with Gβ, Tax1 affects SDF-1
dependent activation of the CXCR4 GPCR chemokine
receptor. Tax1 enhances response to SDF-1 resulting in
MAPK pathway over-activation and increased cell chemo-
taxis. The HTLV-1 associated pathologies (ATL, HAM/TSP
and dermatitis) are characterized by invasion and accu-
mulation of infected T-cells in organs such as lymph
nodes, central nervous system or dermis [194]. These
results thus provide a rationale for the mechanisms of cell
migration observed in HTLV-1 associated pathologies.
3.5 Phosphatidylinositol 3-kinase and AP-1
Phosphatidylinositol 3-kinase (PI3K) and its downstream
effector Akt play a pivotal role in regulation of nutrient
metabolism, cell survival, motility, proliferation and
apoptosis. The PI3K family comprises eight members
divided into three classes according to their sequence
homology and substrate preference [195,196]. PI3K acti-
vation results in phosphorylation of Akt at Ser473 which inRetrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
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turn triggers a broad range of regulatory proteins and tran-
scription factors like AP1 [197].
PI3K-Akt is activated in Tax1-transformed murine fibrob-
lasts and is required for cell transformation [198]. Tax1
complexes with the p85α regulatory subunit of PI3K
[199] and inhibits activity of the p110α catalytic protein.
p85α/p110α belong to the class IA PI3Ks and are acti-
vated by receptor tyrosine kinases, by Ras and Rho family
GTPases and by Gβγ subunits from heterotrimeric G-pro-
teins [200]. Since monomeric p110 is unstable and is rap-
idly degraded, activation of p85α/p110α does not involve
the complex dissociation but would rather depend on
conformational changes [201,202]. Tax1 targets p85α and
disrupts the p85α/p110α complex leading to increased
PI3K activity [203], Akt Ser473 phosphorylation, AP1 acti-
vation and ultimately cell proliferation. Consistent with
this model, ATL cells display constitutive activation of
AP1 [199,204,205].
3.6 Smad proteins
Transforming growth factor β (TGFβ) inhibits T cell
growth in mid-G1 but can also promote tumorigenesis
[206]. TGFβ binds to a heterodimeric complex composed
of type I (TβRI) and type II (TβRII) serine/threonine
kinase receptors [207]. Upon binding of a TGFβ ligand,
TβRII recruits and activates TβRI, which, in turn, phospho-
rylates downstream targets such as Smad proteins
(Smad1-2-3-5-8, receptor activated R-Smad). Common
mediator Co-Smad (Smad4) containing complexes then
translocate to the nucleus and activate transcription of
genes under the control of a Smad-binding element. Sig-
nal termination is further mediated by inhibitory Smad (I-
Smad) Smad6 and Smad7 [207].
Due to constitutive AP1 activation, ATL cells produce high
levels of TGFβ in the sera of HTLV-1 infected patients
[208]. TGFβ does not inhibit growth of HTLV-1 infected
CD4+ cells but affects CD8-dependent response a mecha-
nism that may impact on immune surveillance [209]. Fur-
thermore, TGFβ stimulates cell surface expression of
proteins involved in HTLV binding and fusion (Glut1),
leading to enhanced virus transmission and production
[210,211].
Tax1 inhibits Smad-dependent signaling, thereby promot-
ing resistance of HTLV-1 infected cells to TGFβ
[184,212,213]. This inhibition is mediated by Tax1 inter-
action with the aminoterminus of Smad2, Smad3, and
Smad4 [212]. Through these interactions, Tax1 inhibits
complexation and DNA binding of Smad3-Smad4
[184,212]. Furthermore, Tax1 may compete with Smads
for the recruitment of CBP/p300 [213].
3.7 Cas-L and p130Cas
Proteins belonging to Crk-associated substrate (Cas) fam-
ily are multiadaptator and scaffold molecules that spa-
tially and temporally control signal transduction
downstream of integrins, receptors protein tyrosine
kinase, estrogen receptors and GPCRs. Upon binding of a
ligand to these receptors, Cas proteins are tyrosine phos-
phorylated and recruit adaptors and effectors (such as
small GTPase) to activate downstream targets such as JNK
and ERK. As a result, Cas proteins regulate cell survival,
apoptosis and migration. Furthermore, deregulation of
Cas functions has been linked to cell transformation,
invasion and cancer [214].
Among Cas proteins, Tax1 associates with p130Cas and
CasL (lymphocyte type) [215]. CasL, which is preferen-
tially expressed in lymphocytes [216], is phosphorylated
and over-expressed in Tax1-expressing cells, in Tax1-trans-
genic mice as well as in primary lymphocytes isolated
from ATL patients [215,217]. The Tax1 and CasL interplay
results in enhanced motility of Tax1-expressing lym-
phocytes in response to fibronectin and CD3 [215]. Since
CasL also participates in RhoGTPase activation, Tax1
could interconnect cytoskeleton proteins, stimulate
cytoskeleton rearrangement and enhance the motility of
leukemic cells.
3.8 Global effects of Tax1-mediated deregulation of cell 
signaling pathways
As schematized on figure 2, Tax1 interactions with a series
of components of several signaling pathways (MAPK,
JNK, NF-κB, G proteins, AP1 and TGFβ) affect multiple
cellular processes among which cellular activation, prolif-
eration, cytoskeleton rearrangement, cell migration and
formation of the virological synapse.
4 Interaction of Tax1 with cell cycle associated 
proteins
4.1 Cyclin D-CDK4/6 complexes, Rb and CDK inhibitors
Cell cycle progression is a tightly regulated process con-
trolled by cyclins associated with cyclin-dependent
kinases (CDK). Cyclins D and E cooperate with CDK4/6
and CDK2 to mediate passage through G1 phase and G1/
S transition, respectively [218]. Cyclin D-CDK4/6 and
Cyclin E-CDK2 complexes target the Rb retinoblastoma
protein (Figure 3). In its hypophosphorylated form, Rb is
bound to the transcription factor E2F1, and upon phos-
phorylation, Rb frees E2F1, which activates transcription
of genes required for transition from G1 to S. G1/S pro-
gression can be inhibited by CDK inhibitors (CDKI) such
as p15INK4b, p16INK4a, p18INK4c and p19INK4d by preventing
cyclin D/CDK4/6 complex formation. Tax1 reprograms
cell cycle progression, particularly at G1/S transition,
through different mechanisms pertaining to transcrip-Retrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
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tional activation or repression, post-translational modifi-
cations and protein-protein interactions [219,220].
Tax1 is able to interact with cyclins-D1, -D2 and -D3 as
well as with CDK4 and CDK6 but not with CDK1 or
CDK2 [221-224]. Through these interactions, Tax1 stabi-
lizes the cyclin D2/CDK4 complex and enhances its
kinase activity, leading to hyperphosphorylation of retin-
oblastoma protein (Rb). Tax1 also associates with
p15INK4b and p16INK4a and counteracts their inhibitory
activity of CDK4 [225-228]. Finally, Tax1 binds to and tar-
gets Rb for proteosomal degradation [229]. Consistently,
HTLV-1 infected cell lines and freshly isolated ATL cells
display decreased levels of Rb protein.
Figure 3A illustrates Tax1 interactions with components of
the cyclin D/CDK complexes and provides a mechanistic
model for increased G1-S phase transition efficiency as
well as the accelerated cell proliferation measured in vivo
[230,231].
4.2 DNA repair pathway associated proteins
DNA insults and replication stress activate the DNA dam-
age response (DDR) pathway in S and G2/M phases of the
cell cycle. Activation of the DDR pathway leads to cell
cycle delay or even apoptosis of severely damaged cells,
and activates the DNA repair pathway. ATM (Ataxiatel-
angiectasia mutated) and ATR (ATM-Rad3) proteins and
their respective downstream targets Chk2 (checkpoint
kinase 2) and Chk1 (checkpoint kinase 1) proteins play a
central role in the DDR pathway [232]. In mammals,
Chk1 and Chk2 regulate Cdc25, Wee1 and p53 that ulti-
mately inactivate CDKs which inhibit cell-cycle progres-
sion. Double-strand breaks usually activate the ATM/
Chk2-dependent pathway whereas ATR/Chk1 responds to
a wide variety of lesions and replication blocks [233,234].
Overview of cell signaling proteins targeted by Tax1 Figure 2
Overview of cell signaling proteins targeted by Tax1. Tax1 interacts with components of several signaling pathways 
(MAPK, JNK, NF-κB, AP-1 and TGF-β) and promotes cellular activation, proliferation, cytoskeleton rearrangement, cell migra-
tion and formation of the virological synapse.
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Tax1-expressing and ATL cells display DNA damages sug-
gesting that Tax1 abrogates cellular checkpoint and DNA
repair [235-237]. Tax1 binds Rad51 [130] and DNA
Topoisomerase 1 [135] that are both directly involved in
DNA repair processes [232,238]. Moreover, Tax1 associ-
ates and colocalizes with Chk1 and Chk2 proteins [239-
242]. De novo Tax1 expression causes phosphorylation of
Chk2 resulting in accumulation of cells in S-G2/M
[239,243]. However, upon gamma irradiation, Tax1
inhibits Chk1 and Chk2 kinase activities and attenuates
G2/M arrest and apoptosis, respectively [240,241]. Tax1
thus activates and represses checkpoint controls depend-
ing on the experimental conditions (figure 3B). In fact,
Tax1 sequesters phosphorylated Chk2 within chromatin
after gamma irradiation-induced DNA-damage [242].
Tax1 thereby impedes phosphorylated Chk2 chromatin
egress, a mechanism required for further signal amplifica-
tion and transmission [244]. Tax1 thus targets multiple
components of DNA damage repair pathway and pro-
motes DNA abnormalities.
4.3 Centrosome associated proteins and spindle assembly 
checkpoint
One of the hallmarks of Tax1-expressing cells particularly
in ATL is chromosomal instability and severe aneuploidy
[235], suggesting that mechanisms monitoring chromo-
somal segregation during mitosis are subverted by Tax1.
Tax1 interacts with 4 proteins involved in centrosome
amplification or in mitotic spindle assembly checkpoint
(SAC) (Figure 3C).
4.3.1 RanBP1 and Tax1BP2
The presence of two centrosomes at mitosis is crucial for
formation of bipolar mitotic spindles and correct chromo-
some segregation. Multipolar mitosis which happens
when more than two centrosomes emerge in one cell is a
possible cause of aneuploidy in solid tumors and leuke-
mias [245]. Supernumerary centrosomes are observed in
approximately 30% of ATL cells [246-248]. Tax1 colocal-
izes with the centrosome during mitosis and causes cen-
trosome amplification through physical interaction with
Ran/Ran Binding protein 1 (RanBP1) and Tax1BP2
[249,250]. RanBP1 is involved in the Ran GTP cycle that
controls microtubule nucleation and/or stabilization and
centrosome cohesion during mitosis [251,252]. Centro-
some fragmentation requires direct Tax1/RanBP1 interac-
tion and Tax1's ability to transactivate NF-κB. Tax1BP2 is
thought to act as an intrinsic block to centrosome overrep-
lication [253]. Consistently, overexpression of Tax1BP2
abolishes Tax1-induced centrosome amplification. On
the other hand, a Tax1 mutant unable to bind to Tax1BP2
is impaired in centrosome overreplication [250].
4.3.2 Mad1 and cdc20
In eukaryotes, the mitotic spindle assembly checkpoint
(SAC) monitors the fidelity of chromosome segregation
[254]. SAC functioning requires complex formation
between Mad1-2-3 and Bub1-2-3 proteins that arrest
mitosis in response to microtubule damage [255]. At the
molecular level, SAC activation involves formation of
inhibitory complexes between Mad2 and/or Mad3/BubR1
and Cdc20, preventing Cdc20 from activating the ana-
phase promoting complex/cyclosome (APC/C). APC/C is
active during mitosis where it mediates ubiquitination
and degradation of an inhibitory chaperone of separase
called securin. Once liberated from its inhibitor, separase
triggers anaphase by hydrolysing cohesin leading to sub-
sequent separation of sister chromatin. Furthermore,
Effect of Tax1 on cell cycle progression Figure 3
Effect of Tax1 on cell cycle progression. Through a series of interactions with cell-cycle associated proteins, Tax1 accel-
erates G1/S transition (A), attenuates Chk1/2 activity (B), induces supernumerary centrosomes and impedes SAC (spindle 
assembly checkpoint) activity (C).
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APC/C regulates the degradation of mitotic cyclin, acti-
vates CDK1 and, ultimately, promotes mitotic exit [256].
Through physical interactions with Mad1 and Cdc20,
Tax1 subverts activation of SAC and APC/C. Tax1 inhibits
Mad1 homodimerization, a process that is required for
formation of a inhibitory complex between Mad2 and
Cdc20 [257-259]. Consistently, ATL cells exhibit a defect
in the mitotic spindle assembly checkpoint [257]. On the
other hand, Tax1 associates with and activates Cdc20-
associated APC/C leading to unscheduled degradation of
securin and cyclin B1, a delay or failure in mitotic entry
and progression, and faulty chromosome transmission
[260,261]. Tax1-induced premature activation of APC/C
provokes permanent G1 arrest and senescence [262,263].
Finally, coexpression of Tax1 and securin enhances chro-
mosomal instability and favors cell transformation in vitro
and in vivo [264].
5 Interaction of Tax1 with PDZ-containing 
proteins
The PSD-95/Drosophila  Discs Large/Zona Occludens-I
(PDZ) domain containing proteins form signaling com-
plexes at the inner surface of the cell membrane and are
involved in a very broad range of functions like cell sign-
aling, adhesion, tight-junction integrity, molecular scaf-
folding for protein complexes and tumor suppression
[265-267]. Numerous PDZ proteins have been shown to
form a complex with Tax1 owing to its PDZ binding motif
(PBM) located in the C-terminus (ETEV) [268]: Pro-IL16
(precursor of interleukin 16) [269], hDLG (Drosophila
Discs Large) [270,271], PSD-95, beta-syntrophin, lin-7
[268], Tip1 (Tax1 Interaction protein 1) [272], MAGI3
(Membrane Associated Guanylate kinase with inverted
orientation 3) [273], hTid1 [274] and hScrib [275]. Inter-
action of Tax1 with these PDZ proteins frequently leads to
their delocalization [273,275,276]. Functionally, PDZ
proteins such as hTid1 and hScrib participate to Tax1-
mediated activation of NF-κB and NFAT pathways, respec-
tively [274,275].
A Tax1-binding protein, hDLG, has been particularly stud-
ied owing to its ability to act as a tumor suppressor. hDLG
acts downstream of the Wnt/frizzled pathway and binds
to the adenomatous polyposis complex (APC) which
mediates cell cycle progression [277,278]. APC-hDLG
complex formation negatively regulates G1 to S transition
and plays an important role in transducing the APC cell
cycle blocking signal [277]. Besides, hDLG is also
involved in maintenance and modulation of T cell polar-
ity [279]. Through PBM/PDZ domain interaction, Tax1
induces hyperphosphorylation of hDLG, affects its locali-
zation [276] and prevents its binding to APC [271]. Inter-
estingly, hDLG inactivation increases the ability of Tax1 to
transform a mouse T-cell line [280].
The Tax1 PBM is critically involved in transformation of
rat fibroblasts and IL2 independent growth of mouse lym-
phocytes [276,281] and to promote virus-mediated T-cell
proliferation in vitro and persistence in vivo [282]. In con-
trast, HTLV-2 Tax2 protein which does not harbor a PBM
has a lower transforming activity than Tax1 [283].
6 Tax1 interaction with nuclear pore and 
secretory pathway proteins
Tax1 shuttles between the cytoplasm and the nucleus by
virtue of a nuclear localization sequence (NLS) and a
nuclear export signal (NES) [284-286]. In the nucleus,
Tax1 is primarily located in interchromatin granules or
spliceosomal speckles [141]. In the cytoplasm, Tax1 local-
izes to organelles associated with the cellular secretory
process including the endoplasmic reticulum and Golgi
complex [192,287]. Tax1 is also secreted in the superna-
tant of HTLV-1 infected cells isolated from HAM-TSP
patients [287-289] and may behave as an extracellular
cytokine. Tax1 shuttling is mediated through interaction
with proteins involved in nuclear import, cytoplasmic
export and secretory pathways [289-293].
6.1 Nucleoporins
Nucleoporins of the nuclear pore complex (NPC) form a
channel spanning the double lipid bilayer of the nuclear
envelope. Nuclear pore complexes allow passive diffusion
of ions and small proteins but translocation of cargoes
larger than 40 kDa generally requires specific transport
proteins [294]. Import of cargo proteins containing a clas-
sical NLS is mediated by the importin α/β dimer and
requires metabolic energy which is provided by Ran GTP
[295]. In contrast, carrier-independent translocation of
proteins into the nucleus is energy independent and
requires direct interactions with nucleoporins [295].
Nuclear import and export of Tax1 are both carrier and
energy independent but relies on the interaction between
Tax1 and the p62 nucleoporin [290]. This interaction is
mediated by the aminoterminal zinc-finger motif of Tax1.
Consistently, mutations within this motif abolishes Tax1
interaction with p62 and nuclear import [290].
6.2 Proteins involved in Tax1 nuclear export and secretion
Proteins containing a NES domain like Tax1 are expected
to interact with the chromosome region maintenance 1
protein (CRM1), a member of the importin β family
[296]. Under stress conditions (i.e. UV irradiation), Tax1
interacts with CRM1 and is exported outside of the
nucleus, a mechanism that is inhibited by leptomycin B
[291,292]. In the absence of stress however, leptomycin B
does not alter subcellular distribution of Tax1 [286], sug-
gesting that Tax1 is not exclusively exported through the
CRM1 pathway.Retrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
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Tax1 nucleo-cytoplasmic shuttling and secretion is
directed by associations with proteins involved in nuclear
export (calreticulin, RanBP2, p97), in ER to Golgi trans-
port (the coat proteins (COP) βCOP and COPII) and in
movement from Golgi to plasma membrane (secretory
carrier membrane protein 23 (SNAP23), secretory carrier
membrane protein 1 and 2 (SCAMP1, SCAMP2))
[289,293,297]. Calreticulin, which is overexpressed in
HTLV-1 infected cells, functions similarly to CRM1 by
transporting proteins via NES interactions [293,298].
Tax1 secretion involves a secretory signal located in the C-
terminal domain and requires interaction with SNAP23,
SCAMP1 and COPII [289].
Tax1 thus targets different cellular factors involved in pro-
tein transport to shuttle between nucleus, cytoplasm and
extracellular environment.
7 Binding domains in Tax1
To interact with such a broad range of cellular targets,
Tax1 contains multiple protein-binding domains (Figure
4). Among these, the N-terminal zinc finger motif associ-
ates with transcription factors (CREB/ATF [299], TBP [90],
Ets1 [62], NF-YB [82], Egr1 [85]), cyclins [221], nucleo-
proteins (p62) [290], proteasome subunits [163] and
phosphatase PP2A [168]. Mutations within this zinc fin-
ger affects Tax1-mediated CREB transactivation as well as
subcellular localization due to the presence of a NLS
[284]. A domain encompassing residues 55 to 95 regulate
interaction of Tax1 with CBP/p300, Chk2 and Gβ2
[102,241,300]. The middle of Tax1 harbors a region
required for dimerization, two leucine zipper-like motifs
(aa 116–145 and 213–248) [39,301,302] and a NES
sequence [291]. Substitutions within the first leucine zip-
per (such as T130A and L131S in mutant M22) affect Tax1
interactions with NF-κB [157,301], proteasome subunits
[163] and PP2A [168]. Another mutation (S132A) abol-
ishes Tax1 binding to coil-coiled domain containing pro-
teins [303] (i.e. Mad1, Tax1BP1, Tax1BP2 and GPS2). A
region located between the two leucine zippers is required
for interaction with CARM-1, Chk2 and Gβ2
[127,241,300]. Amino acids 233–246, located within the
second leucine zipper regulates Tax1 association with
p15INK4b [228], p16INK4a [226], DNA topoisomerase [135]
Functional regions of Tax1 and interaction domains Figure 4
Functional regions of Tax1 and interaction domains. NLS (nuclear localization sequence), NES (nuclear export 
sequence), G (Golgi localization motif), S (secretion motif), LZR (leucine-zipper-like region), P (PDZ binding domain). Adapted 
from [130].
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and IκBγ [161]. Consistently, the central region of Tax1 is
indeed involved in NF-κB activation. Finally, the carboxy-
terminal region of Tax1 contains an activation domain
(residues 289–332) [304] as well as motifs required for
Tax1 localization within the Golgi (residues 312–315)
and secretion (residues 330–332) [297]. The carboxyter-
minal domain is involved in Tax1 binding to Rb [229],
PI3K [199], P/CAF [102], P-TEFb [138] and PDZ contain-
ing-proteins [268]. In particular, Tax1 mutant M47
(L319R, L320S) is impaired for interaction with P/
CAF[102].
8 Conclusion
The most intriguing point relating to the Tax1 interactome
is the very high number of cellular proteins to which this
viral oncogene is able to interact. Today, about 100 Tax1-
binding proteins are identified (Table 1) and this number
is permanently growing (see http://www.htlv-tax.com/ for
regular updates). Is it possible that a single protein mod-
ulates such a wide variety of functions? Are these interac-
tions all relevant for the viral life cycle or pathogenesis? As
schematized on Figure 5, the vast majority of these inter-
actions contributes to viral or cellular gene expression and
promotes infected cell proliferation or survival, required
for maintaining viral load in vivo [231,305]. On the other
hand, checkpoint abrogation allows proliferation of cells
with DNA lesions and progressive accumulation of chro-
mosomal abnormalities as frequently observed in ATL
[220]. Even if one might entertain doubts about the bio-
logical relevance of some Tax1 partners, the Tax1 interac-
tome as a whole likely contributes to the viral life cycle as
well as to development of pathogenesis.
Other viral oncogenes such as Kaposi's sarcoma-associ-
ated herpesvirus-encoded LANA and adenovirus E1A also
interact with numbers of cellular proteins (e.g. more than
40 for E1A and 100 for LANA) [306,307]. Interestingly,
some of these proteins are targeted both by Tax1 and E1A
(such as ATF, CBP, p300 or Smad), indicating that similar
signaling pathways are involved in distinct viral systems
to achieve cell transformation. In particular, Tax1 and E1A
share common properties that include regulation of tran-
scriptional activation, chromatin remodeling, interference
with p53 activity, regulation of proteasome function and
cooperation with Ras in cell transformation [308].
How are these different activities controlled temporarily
and spatially? Additional studies are definitely required to
address this point. Currently, Tax1 is known to shuttle
between cytoplasm and nucleus, to form intranuclear
Overview of the Tax1 interactome Figure 5
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speckles along with a series of cellular proteins (e.g. NF-κB
factors [309], sc35 [141] and chk2 [239]) and to target
specialized structures such as the centrosome [249,250].
Moreover, Tax1 localisation and protein interactions are
altered under stress conditions [291,292].
Despite numbers of attempts, Tax1 3-D crystallographic
structure is intriguingly still unsolved suggesting that Tax1
adopts a rather undefined conformation. In this context,
the concept of intrinsically disordered proteins (IDP) has
recently emerged [310]. IDPs contrast to "ordered" pro-
teins that fold into a unique and structured state, which
represents a kinetically accessible and energetically favora-
ble conformation. IDP proteins contain one or multiple
disordered regions that exist as dynamic ensembles in
which atom positions and backbone Ramachandran
angles vary significantly with no specific equilibrium val-
ues [310]. The presence of short (< 30 residues) and long
(> 30 residues) ID regions confer conformationnal flexi-
bility thereby facilitating post-translational modifications
and enabling a protein to functionally interact with many
cellular partners [310,311]. Consistently, IDPs are fre-
quently highly connected 'hubs' in the protein-protein
networks [311-313]. In fact, Tax1 contains many proline
(n = 40), serine (n = 25) and glycine (n = 25) residues that
are known to promote disorder [310]. According to the
VSL1 prediction programme (PONDR®, http://
www.pondr.com), Tax1 contains multiple ID regions (n =
6) (Figure 6). In particular, Tax1 contains a long disor-
dered region (spanning amino-acids 76 to 121), in con-
trast to the well structured capsid (p24), transmembrane
(gp21) and surface (gp46) proteins (data not shown).
Interestingly, other viral oncogenes such as HPV E6 and
E7 are also predicted to contain significant intrinsic disor-
der [314].
Identification of disordered regions in Tax1 according to the  VSL1 algorithm Figure 6
Identification of disordered regions in Tax1 accord-
ing to the VSL1 algorithm. (PONDR®, http://
www.pondr.com). A domain encompassing residues 76 to 
121 (black bar) corresponds to a long disordered region 
within Tax1.
Table 1: Cellular proteins interacting with Tax1
Transcription and translation Cell signaling
ATF1 [28] CasL [215]
ATF2 [30] Cdc42 [130]
ATF3 [27] Gap1m [130]
ATF4 [29] GPS2 [183]
ATFx [42] Gβ2 [300]
BAF155 [130] IKKα [159]
BAF53 [130] IKKβ [159]
BAF57 [130] IKKγ [156]
BRG1 [130] IκBα [162]
C/EBPβ [81] IκBγ [161]
CARM1 [127] MEKK1 [157]
CREB [26] p100 [317]
c-Rel [75] p105 [163]
CREM [28] p130Cas [215]
Cyclin T1 [138] p85α [199]
DNA topoisomerase I [135] PP2A [168]
Egr1 [85] Rac [130]
Elk1 [63] RhoA [130]
Ets1 [62] Smad2 [213]
HDAC1 [119] Smad3 [213]
Int6 [149] Smad4 [213]
JMJD2A [125] TAB2 [181]
MBD2 [123] TAK1 [158]
MSX2 [89] Tax1BP1 [171]
NF-YB [82] Ubc13 [170]
NRF1 [88]
p/CAF [101]
p300/CBP [100]
p50 [61] PDZ proteins
p52 [74] beta-syntrophin [268]
RelA [75] hDLG [270]
RPL6 [318] hScrib [275]
Sap1 [63] hTid1 [274]
Sc35 [141] lin7 [268]
SMRT [122] MAGI3 [273]
Sp1 [62] Pro-IL16 [269]
Spi-1 [81] PSD95 [268]
SRF [59] Tip1 [272]
SUV39H1 [124]
TAFII28 [91]
Tax1BP1 [144]
TBP [90] Transport
TFIIA [92] Calreticulin [289]
TORC1 [44] COPII [289]
TORC2 [44] CRM1 [291]
TORC3 [43] p62 [290]
TRBP [150] p97 [289]
TTP [148] RanBP2 [289]
XBP1 [31] SCAMP1 [289]
SCAMP2 [289]
SNAP23 [289]
Cell cycle and DNA repair βCOP [289]Retrovirology 2008, 5:76 http://www.retrovirology.com/content/5/1/76
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On the other hand, Tax1 is modified by phosphorylation,
ubiquitination and sumoylation that potentially modu-
late its functions, localisation and interactions [76,315].
Tax1 also contains 8 cysteines that may form disulfite
bonds or coordinate zinc ions and 48 leucines that are
considered as order-promoting residues [310]. Tax1 thus
appears as a flexible structure formed by a series of small
modular domains that are relatively independent of sur-
rounding sequences and that permits wide conforma-
tional changes depending upon its subcellular
environment.
We propose that, similarly to the hubs, the ID-based struc-
ture of Tax1 allows a wide variety of conformational
changes enabling binding diversity and recognition of dif-
ferently shaped protein partners. Flexible accommodation
at various binding interfaces would then allow interaction
of more structured domains such as the Tax1 zinc finger
and leucine containing helices. This hypothetical model
provides a rationale to the very broad range of Tax1 inter-
acting proteins identified so far.
In conclusion, the Tax1 interactome network with the
associated biochemical studies reported here provides a
molecular basis for understanding viral persistence and
pathogenesis, paving the way for the design of com-
pounds to antagonize its ability to mediate cell transfor-
mation.
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